137 related articles for article (PubMed ID: 2339414)
1. Pharmacokinetics of [125I]-2-iodo-3,7,8-trichlorodibenzo-p-dioxin in mice: analysis with a physiological modeling approach.
Leung HW; Poland A; Paustenbach DJ; Murray FJ; Andersen ME
Toxicol Appl Pharmacol; 1990 May; 103(3):411-9. PubMed ID: 2339414
[TBL] [Abstract][Full Text] [Related]
2. A physiological pharmacokinetic description of the tissue distribution and enzyme-inducing properties of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat.
Leung HW; Paustenbach DJ; Murray FJ; Andersen ME
Toxicol Appl Pharmacol; 1990 May; 103(3):399-410. PubMed ID: 2160135
[TBL] [Abstract][Full Text] [Related]
3. A physiologically based pharmacokinetic model for 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice.
Leung HW; Ku RH; Paustenbach DJ; Andersen ME
Toxicol Lett; 1988 Jul; 42(1):15-28. PubMed ID: 2838936
[TBL] [Abstract][Full Text] [Related]
4. Disposition of 2,3,7,8-tetrabromodibenzo-p-dioxin and 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat: biliary excretion and induction of cytochromes CYP1A1 and CYP1A2.
Kedderis LB; Diliberto JJ; Linko P; Goldstein JA; Birnbaum LS
Toxicol Appl Pharmacol; 1991 Oct; 111(1):163-72. PubMed ID: 1949032
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of in vivo hepatic uptake and in vitro hepatic binding of [125I]2-lodo-3,7,8-trichlorodibenzo-p-dioxin by the administration of agonist for the Ah receptor.
Poland A; Teitelbaum P; Glover E; Kende A
Mol Pharmacol; 1989 Jul; 36(1):121-7. PubMed ID: 2546046
[TBL] [Abstract][Full Text] [Related]
6. Tissue distribution after a single subcutaneous administration of 2,3,7,8-tetrabromodibenzo-p-dioxin in comparison with toxicokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Wistar rats.
Nagao T; Yamashita K; Golor G; Bittmann H; Körner W; Hagenmaier H; Neubert D
Life Sci; 1996; 58(4):325-36. PubMed ID: 8538369
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. 1. Dose-dependent tissue distribution and induction of hepatic ethoxyresorufin O-deethylase in rats following a single injection.
Abraham K; Krowke R; Neubert D
Arch Toxicol; 1988; 62(5):359-68. PubMed ID: 3242446
[TBL] [Abstract][Full Text] [Related]
8. [125I]2-iodo-3,7,8-trichlorodibenzo-p-dioxin-binding species in mouse liver induced by agonists for the Ah receptor: characterization and identification.
Poland A; Teitelbaum P; Glover E
Mol Pharmacol; 1989 Jul; 36(1):113-20. PubMed ID: 2546045
[TBL] [Abstract][Full Text] [Related]
9. 2,3,7,8-Tetrachlorodibenzo-p-dioxin pretreatment of female mice altered tissue distribution but not hepatic metabolism of a subsequent dose.
Curtis LR; Kerkvliet NI; Baecher-Steppan L; Carpenter HM
Fundam Appl Toxicol; 1990 Apr; 14(3):523-31. PubMed ID: 2340981
[TBL] [Abstract][Full Text] [Related]
10. Extrapolation of a PBPK model for dioxins across dosage regimen, gender, strain, and species.
Wang X; Santostefano MJ; DeVito MJ; Birnbaum LS
Toxicol Sci; 2000 Jul; 56(1):49-60. PubMed ID: 10869453
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity analysis of a physiological model for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): assessing the impact of specific model parameters on sequestration in liver and fat in the rat.
Evans MV; Andersen ME
Toxicol Sci; 2000 Mar; 54(1):71-80. PubMed ID: 10746933
[TBL] [Abstract][Full Text] [Related]
12. The effects of 2,2',4,4',5,5'-hexachlorobiphenyl cotreatment on the disposition of 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice.
De Jongh J; DeVito M; Diliberto J; Van den Berg M; Birnbaum L
Toxicol Lett; 1995 Oct; 80(1-3):131-7. PubMed ID: 7482580
[TBL] [Abstract][Full Text] [Related]
13. The effect of dose on 2,3,7,8-TCDD tissue distribution, metabolism and elimination in CYP1A2 (-/-) knockout and C57BL/6N parental strains of mice.
Hakk H; Diliberto JJ; Birnbaum LS
Toxicol Appl Pharmacol; 2009 Nov; 241(1):119-26. PubMed ID: 19695277
[TBL] [Abstract][Full Text] [Related]
14. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
[TBL] [Abstract][Full Text] [Related]
15. Relationship between the murine Ah phenotype and the hepatic uptake and metabolism of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Shen ES; Olson JR
Drug Metab Dispos; 1987; 15(5):653-60. PubMed ID: 2891482
[TBL] [Abstract][Full Text] [Related]
16. Effect of dose, time, and pretreatment on the biliary excretion and tissue distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat.
Kedderis LB; Andersen ME; Birnbaum LS
Fundam Appl Toxicol; 1993 Nov; 21(4):405-11. PubMed ID: 8253293
[TBL] [Abstract][Full Text] [Related]
17. A physiologically based pharmacokinetic model for 2,3,7,8-tetrabromodibenzo-p-dioxin (TBDD) in the rat: tissue distribution and CYP1A induction.
Kedderis LB; Mills JJ; Andersen ME; Birnbaum LS
Toxicol Appl Pharmacol; 1993 Jul; 121(1):87-98. PubMed ID: 8337704
[TBL] [Abstract][Full Text] [Related]
18. Relative distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin in human hepatic and adipose tissues.
Leung HW; Wendling JM; Orth R; Hileman F; Paustenbach DJ
Toxicol Lett; 1990 Feb; 50(2-3):275-82. PubMed ID: 2309246
[TBL] [Abstract][Full Text] [Related]
19. Comparative dermal absorption of 2,3,7,8-tetrachlorodibenzo-p-dioxin and three polychlorinated dibenzofurans.
Brewster DW; Banks YB; Clark AM; Birnbaum LS
Toxicol Appl Pharmacol; 1989 Jan; 97(1):156-66. PubMed ID: 2916232
[TBL] [Abstract][Full Text] [Related]
20. Use of a physiologically based pharmacokinetic model for rats to study the influence of body fat mass and induction of CYP1A2 on the pharmacokinetics of TCDD.
Emond C; Birnbaum LS; DeVito MJ
Environ Health Perspect; 2006 Sep; 114(9):1394-400. PubMed ID: 16966094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
